Essential Thrombocythemia

Showing NaN - NaN of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Essential Thrombocythemia Trial in Worldwide (Ropeginterferon alfa-2b, Anagrelide)

Recruiting
  • Essential Thrombocythemia
  • Phoenix, Arizona
  • +60 more
Dec 30, 2021

Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in

Completed
  • Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
  • +13 more
  • Salt Lake City, Utah
  • +2 more
Jan 15, 2020

Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia:

Completed
  • Polycythemia Vera
  • +2 more
    • Salt Lake City, Utah
      University of Utah
    Oct 14, 2019

    Research Tissue Bank

    Completed
    • Myelofibrosis
    • +3 more
      • Palo Alto, California
      • +10 more
      Jul 2, 2019

      Patients With Myeloproliferative Disorders

      Completed
      • Myeloproliferative Disease
      • +4 more
        • Scottsdale, Arizona
        • +21 more
        Dec 12, 2018

        Familial Myeloproliferative Disorders

        Completed
        • Polycythemia Vera
        • +2 more
          • Washington, D.C., District of Columbia
          • +5 more
          Sep 1, 2017

          Myeloproliferative Tumors of, Polycythemia Vera, Essential Thrombocythemia Trial in United States (LY2784544)

          Completed
          • Myeloproliferative Neoplasms of
          • +3 more
          • Birmingham, Alabama
          • +8 more
          Apr 10, 2017

          Myelofibrosis, Essential Thrombocythemia, Polycythemia Vera Trial in United States (CEP-701 (Lestaurtinib))

          Unknown status
          • Myelofibrosis
          • +2 more
          • CEP-701 (Lestaurtinib)
          • Palo Alto, California
          • +6 more
          Nov 24, 2014